|Bid||2.5900 x 21500|
|Ask||2.6000 x 39400|
|Day's range||2.5500 - 2.6850|
|52-week range||1.0100 - 6.4500|
|Beta (5Y monthly)||1.44|
|PE ratio (TTM)||N/A|
|Earnings date||19 Jul 2021 - 23 Jul 2021|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
Organigram Holdings Inc. ("Organigram" or the "Company") (TSX: OGI) (NASDAQ: OGI), the parent company of Organigram Inc., a leading producer of cannabis, is pleased to announce the appointment of Borna Zlamalik as the Company’s Vice President of Innovation. Mr. Zlamalik will assume his new role effective today.
The only company-specific news around OrganiGram came earlier this week when the company surprised investors with news that CEO Greg Engel will be leaving that role immediately and that his interim replacement is the board's chairman, Peter Amirault. Jefferies analyst Owen Bennett upgraded fellow Canadian cannabis company Tilray (NASDAQ: TLRY) today with a double bump up to a buy rating. Bennett assigned Tilray a price target representing more than 60% upside in the name.
Of course, a low share price doesn't necessarily mean a stock is cheap. A high share price doesn't necessarily mean a stock is expensive, either. In many cases, penny stocks (which today include any stock with a share price below $5) are actually valued unattractively.